Does TRASTUZUMAB Cause Hepatitis b reactivation? 98 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Hepatitis b reactivation have been filed in association with TRASTUZUMAB (Trazimera). This represents 0.2% of all adverse event reports for TRASTUZUMAB.
98
Reports of Hepatitis b reactivation with TRASTUZUMAB
0.2%
of all TRASTUZUMAB reports
86
Deaths
61
Hospitalizations
How Dangerous Is Hepatitis b reactivation From TRASTUZUMAB?
Of the 98 reports, 86 (87.8%) resulted in death, 61 (62.2%) required hospitalization.
Is Hepatitis b reactivation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB. However, 98 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB Cause?
Diarrhoea (4,996)
Off label use (3,802)
Nausea (3,499)
Fatigue (3,417)
Myelosuppression (2,552)
Disease progression (2,449)
Death (2,378)
Vomiting (2,244)
Dyspnoea (2,010)
Pyrexia (1,886)
What Other Drugs Cause Hepatitis b reactivation?
RITUXIMAB (914)
CYCLOPHOSPHAMIDE (801)
DOXORUBICIN (684)
VINCRISTINE (641)
PREDNISONE (583)
PREDNISOLONE (465)
LAMIVUDINE (308)
METHOTREXATE (305)
DEXAMETHASONE (293)
ETOPOSIDE (213)
Which TRASTUZUMAB Alternatives Have Lower Hepatitis b reactivation Risk?
TRASTUZUMAB vs TRASTUZUMAB-ANNS
TRASTUZUMAB vs TRASTUZUMAB DERUXTECAN
TRASTUZUMAB vs TRASTUZUMAB-DKST
TRASTUZUMAB vs TRASTUZUMAB-DTTB
TRASTUZUMAB vs TRASTUZUMAB EMTANSINE